Complete pathological remission and tertiary lymphoid structures are associated with the efficacy of resectable NSCLC receiving neoadjuvant chemoimmunotherapy: A double-center retrospective study

Complete pathological remission and tertiary lymphoid structures are associated with the efficacy of resectable NSCLC receiving neoadjuvant chemoimmunotherapy: A double-center retrospective study

ABSTRACTThis study aimed to investigate the relationship between complete pathological remission (PCR), tertiary lymphoid structure (TLS) maturation and expression and clinical outcomes of patients with resectable non-small cell lung cancer (NSCLC) receiving neoadjuvant chemoimmunotherapy. Totally 8...

Full description

Bibliographic Details
Main Authors: Ying Liu, Lei Xiong, Yue Chen, Ruoxue Cai, Xinyu Xu, Tian Wang, Yiyu Guo, Luxi Ruan, Ying Fang, Quanan Zhang, Bo Shen, Jinjun Ye, Guoren Zhou
Format: Article
Language:English
Published: Taylor & Francis Group 2023-12-01
Series:Human Vaccines & Immunotherapeutics
Subjects:
Tertiary lymphoid structure
neoadjuvant chemoimmunotherapy
complete pathological remission
non-small cell lung cancer
prognosis
Online Access:https://www.tandfonline.com/doi/10.1080/21645515.2023.2285902

Internet

https://www.tandfonline.com/doi/10.1080/21645515.2023.2285902

Similar Items